iradimed corporation develops, manufactures, markets, and distributes magnetic resonance imaging (mri) compatible medical devices, and related accessories and services in the united states and internationally. it offers mri compatible intravenous (iv) infusion pump system with associated disposable iv tubing sets; and mri compatible patient vital signs monitoring system. the company also provides iv poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and spo2 monitoring with sensors and accessories. it serves hospitals, acute care facilities, and outpatient imaging centers. the company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. iradimed corporation was incorporated in 1992 and is headquartered in winter springs, florida.
![Iradimed logo](/files/LOGO/1325618-IRMD.png)
Company profile
Ticker
IRMD
Exchange
Website
CEO
Leslie McDonnell
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
IRMD stock data
Latest filings (excl ownership)
8-K
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global Market
7 Jun 24
8-K
Amendment to Susi, LLC Lease Agreement
3 Jun 24
ARS
2023 FY
Annual report to shareholders
9 May 24
EFFECT
Notice of effectiveness
9 May 24
S-3/A
Shelf registration (amended)
6 May 24
10-Q
2024 Q1
Quarterly report
2 May 24
8-K
IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share
2 May 24
DEF 14A
Definitive proxy
29 Apr 24
S-3
Shelf registration
3 Apr 24
10-K
2023 FY
Annual report
1 Mar 24
Transcripts
IRMD
Earnings call transcript
2024 Q1
2 May 24
IRMD
Earnings call transcript
2023 Q4
8 Feb 24
IRMD
Earnings call transcript
2023 Q3
3 Nov 23
IRMD
Earnings call transcript
2023 Q2
3 Aug 23
IRMD
Earnings call transcript
2023 Q1
4 May 23
IRMD
Earnings call transcript
2022 Q4
2 Feb 23
IRMD
Earnings call transcript
2022 Q3
3 Nov 22
IRMD
Earnings call transcript
2022 Q2
29 Jul 22
IRMD
Earnings call transcript
2022 Q1
29 Apr 22
IRMD
Earnings call transcript
2021 Q4
4 Feb 22
Latest ownership filings
4
MONTY K ALLEN
4 Jun 24
144
Notice of proposed sale of securities
3 Jun 24
SC 13G/A
Susi Roger E.
13 Feb 24
SC 13G/A
Nine Ten Capital Management LLC
12 Feb 24
SC 13G
BlackRock Inc.
9 Feb 24
SC 13G/A
Soleus Capital Master Fund, L.P.
2 Feb 24
4
Roger E. Susi
27 Dec 23
4
Roger E. Susi
22 Dec 23
4
Roger E. Susi
20 Dec 23
4
JAMES B HAWKINS
14 Dec 23
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 45.13 mm | 45.13 mm | 45.13 mm | 45.13 mm | 45.13 mm | 45.13 mm |
Cash burn (monthly) | 1.55 mm | (no burn) | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | 4.12 mm | n/a | n/a | n/a | n/a | n/a |
Cash remaining | 41.01 mm | n/a | n/a | n/a | n/a | n/a |
Runway (months of cash) | 26.5 | n/a | n/a | n/a | n/a | n/a |
Institutional ownership, Q1 2024
14.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 39 |
Opened positions | 29 |
Closed positions | 2 |
Increased positions | 4 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 47.86 bn |
Total shares | 1.89 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Soleus Capital Master Fund | 742.00 k | $0.00 |
Copeland Capital Management | 418.15 k | $18.39 bn |
Russell Investments | 166.88 k | $7.34 bn |
HighTower Advisors | 103.11 k | $4.53 bn |
Rice Hall James & Associates | 76.71 k | $3.37 bn |
BK Bank Of New York Mellon | 53.61 k | $2.36 bn |
Los Angeles Capital Management & Equity Research | 48.86 k | $2.15 bn |
Bridge City Capital | 42.18 k | $1.86 bn |
Fiera Capital | 28.74 k | $1.26 bn |
Conestoga Capital Advisors | 27.66 k | $1.22 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jun 24 | Monty K Allen | Common Stock | Sell | Dispose S | No | No | 43.3654 | 1,947 | 84.43 k | 18,053 |
27 Dec 23 | Susi Roger E. | Common Stock | Sell | Dispose S | Yes | Yes | 46.5094 | 5,000 | 232.55 k | 162,950 |
26 Dec 23 | Susi Roger E. | Common Stock | Sell | Dispose S | Yes | Yes | 46 | 5,000 | 230.00 k | 167,950 |
21 Dec 23 | Susi Roger E. | Common Stock | Gift | Dispose G | Yes | No | 0 | 300,000 | 0.00 | 2,062,500 |
19 Dec 23 | Susi Roger E. | Common Stock | Sell | Dispose S | Yes | Yes | 45.1393 | 5,000 | 225.70 k | 172,950 |
18 Dec 23 | Susi Roger E. | Common Stock | Sell | Dispose S | Yes | Yes | 44.0805 | 5,000 | 220.40 k | 177,950 |
14 Dec 23 | Hawkins James B | Common Stock | Sell | Dispose S | No | No | 44.5843 | 4,277 | 190.69 k | 39,348 |
14 Dec 23 | Hawkins James B | Common Stock | Grant | Acquire A | No | No | 9.84 | 4,277 | 42.09 k | 43,625 |
14 Dec 23 | Hawkins James B | Stock Options Common Stock | Option exercise | Dispose M | No | No | 9.84 | 4,277 | 42.09 k | 0 |
13 Dec 23 | Hawkins James B | Common Stock | Sell | Dispose S | No | No | 43.6137 | 219 | 9.55 k | 39,348 |